Research and commercialization suggesting a new paradigm in the diagnosis and treatment of neuropsychiatric disorders
2020~
Platform Development and Commercialization.
2023
- Entry-level iSyncWave to be released
- Acquired ISO 13485 (2023.03)
- Acquired FDA certification for iSyncBrain-C software medical device (2023.03)
- Participated in CES 2023
2022
- Selected as an excellent design product (Good Design) and won the Minister of SMEs and Startups Award
- Won the grand prize in the bio-health sector at the 4IR Awards (4th Industrial Revolution Awards)
- Acquired FDA 510K certification for iSyncWave as medical device (2022.08)
- iSyncWave selected as an innovative prototype by the Public Procurement Service (2022.06)
- iSyncBrain MCI Classifier, selected as a new medical technology for deferred evaluation (2022.05)
- Awarded the Red Dot Design Award
- Participated in CES 2022
2021
- Series C Funding (6.3 million dollars)
- iSyncWave KFDA registration as Class 2 medical device (2021.12)
- Acquisition iSyncWave GMP cert(2021.11)
- Designated as Innovative Product of the Year by Public Procurement Service
- World Standards Award by Ministry of Trade, Industry, and Energy
- Selected as 4th Industrial Revolution Outstanding Company by Ministry of Health and Welfare
- Establishment of US Subsidiary(2021.7)
- Designated as Innovative Product of the Year by Public Procurement Service
- Selected as High Growth Software company by Ministry of Science and ICT
- Participated in CES 2021. iSyncWave unveiled
2020
- Selected as a participating company of National Dementia Overcoming Project
- Selected as a Preliminary Unicorn Company by Ministry of SMEs and Startups
- KFDA registration
- · EEG analytics, iSyncBrain-C (2020.08)
- · aMCI EEG biomarker, iSyncBrain-M1 (2020.08)
- · HRV analytics, iSyncHeart (2020.07)
- Designated as Big 3 Digital Healthcare Organizer by Ministry of SMEs and Startups
- R&BD Funding(1.2 Million dollars) by Ministry of Trade, Industry, and Energy
- Series B Funding (4.2 Million dollars)
2018~2019
Core technology development
2019
- Selected as an Innovative Startup Project by Ministry of SMEs and Startups
- Successful clinical trial of EEG algorithm for Screening for Amnestic Mild Cognitive Impairment
- Mitsar EEG device KFDA registration and distributorship
- Successful TIPS (Tech Incubator Program for Startup) graduation and Selected as Post TIPS Program Company
- Approval of clinical trial of EEG algorithm for Screening for Amnestic Mild cognitive impairment
2018
- Series A Funding (2.5 million dollars)
2013~2017
Founding and Team building
2017
- Selected as Next-Generation Medical Device 100 Project by KFDA (SW platform for dementia early screening
- Selected as TIPS Program Company by Ministry of SMEs and Startups
2016
- Seed Funding (500 thousand dollars)
2014
- Establishment of a Corporate research institute. (2014.04)
2013
Initiation of Life Span EEG Database Project jointly with National Reference EEG Data Project by Seoul National University(2018)
2012
Founded iMediSync, Inc.